Summary
The development of autoantibodies during interferon therapy is frequent, but clinical symptoms of autoimmune disease are uncommon. We report on a female patient who developed arthritis with strongly positive antinuclear factor (ANA) and autoimmune thyroiditis while being treated with alpha 2b interferon (IFN) for chronic myelocytic leukaemia (CML). The arthritis subsided promptly after discontinuation of IFN and initiation of nonsteroidal anti-inflammatory drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Quesada, J.R., Talpaz, M., Rios, A., Kurzrock, R., Gutterman, J. Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol 1986, 4, 234–243.
Fentiman, J.S., Thomas, B.S., Balkwill, F.R., Rubens, R.D., Hayward, J.L. Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet 1985, 1, 1166.
Akard, L.P., Hoffman, R., Elias, L., Saiers, J.H. Alpha-interferon and immune hemolytic anemia. Ann Intern Med 1986, 105, 306.
Abdi, E.A., Venner, P.M. Immune thrombocytopenia after alpha-interferon therapy in patients with cancer. JAMA 1986, 255, 1878–1879.
Mangan, K.F., Zidar, B., Shadduck, R.K., Zeigler, Z., Winkelstein, A. Interferon-induced aplasia: Evidence for T-cell mediated suppression of hematopoiesis and recovery after treatment with horse antihuman thymocyte globulin. Am J Hematol 1985, 19, 401–413.
Conlon, K.C., Urba, W.J., Smith, J.W., Steis, R.G., Longo, D.L., Clark, J.W. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 1990, 65, 2237–2242.
Schilling, P.J., Kurzrock, R., Kantarjian, H., Gutterman, J.U., Talpaz, M. Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer 1991, 68, 1536–1537.
Rönnblom, L.E., Gunnar, V.A., Kjell, E.O. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991, 115, 178–183.
Chazerain, P., Meyer, O., Kahn, M.F. Rheumatoid arthritis-like disease after alpha-interferon therapy. Ann Intern Med 1992, 116, 427.
Ueno, Y., Sohma, T. Alpha-interferon-induced nodular rheumatoid arthritis in renal cell carcinoma. Ann Intern Med 1992, 117, 266–267.
Maccari, S., Bassi, C., Giovannini, A.G., Plancher, A.C. A case of arthropathy and hypothyroidism during recombinant alpha-interferon therapy. Clin Rheumatol 1991, 10, 452–454.
Wandl, U.B., Nagel-Hiemke, M., May, D., Kreuzfelder, E., Kloke, O., Moritz, T., Kranzhoff, M., Anders, C., Seeber, S., Niederle, N. Antinuclear antibodies before and during interferon treatment in patients with myeloproliferative disease. Blood 1991, 10, 31a.
Mayet, W.J., Hess, G., Gerken, G., Rossol, S., Voth, R., Mann, M., Meyer zum Buschenfelde K.H. Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 1989, 10, 24–28.
Kluin-Nelemans, J.F., van den Burgh, J.F., Louwagie, A., Delannoy, A., Boogaerts, M.A., Bosly, A., Michaux, J.L., van den Berghe, H., Hagemeijer, A. Interferon alpha therapy for CML: preliminary report of a large multicenter randomized study. Data presented at 2nd International Conference on Chronic Myeloid Leukemia, Bologna, Italy, October, 1992 (abstr 97).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
D'Hondt, L., Delannoy, A. & Docquier, C. Hypothyroidism and arthritis during interferon therapy. Clin Rheumatol 12, 415–417 (1993). https://doi.org/10.1007/BF02231591
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02231591